Lipidor AB is a Swedish company based in Stockholm that specializes in developing topical products with unique lipid-based formulations. With a focus on Pharma, Consumer Healthcare, and Animal Care, Lipidor offers innovative solutions to improve patients' quality of life. Established in 2009 by a team of experienced researchers in lipid technology, Lipidor aims to create advanced vehicle concepts for dermatology applications.

After confirming feasibility and obtaining intellectual property rights, the company develops and licenses products across various dermatological areas. Lipidor conducts its research and development activities at Stockholm University and Karolinska Institutet Science Park, while GMP development and production for early stage and clinical trials are performed in collaboration with Cerbios-Pharma SA (Pharma) and Aurena Laboratories AB (Consumer Healthcare and Animal Health). Their vision is to establish their patented technology, AKVANO®, as one of the preferred delivery systems for dermatological products, while their mission is to develop lipid-based topical products that truly enhance patients' lives.

Under the leadership of Ola Holmlund as CEO, the management team, which includes CFO Charlotta Ekman, CSO Jan Holmbäck, and CDO Anders Hagman, brings extensive expertise in sales, finance, scientific research, and development. The board of directors is composed of professionals with diverse backgrounds and experiences in the life science industry. Led by chairman Fredrik Sjövall, the directors provide strategic guidance and governance to drive Lipidor's growth and success.

The founders, Bengt Herslöf and Anders Carlsson, serve as senior scientific advisors, leveraging their extensive knowledge and experience in lipid sciences and pharmaceutical development. With a commitment to advancing topical treatments and enhancing patients' well-being, Lipidor is at the forefront of lipid-based formulation innovation, striving to make a positive impact in dermatology and related fields